Oral eplerenone for the management of chronic central serous chorioretinopathy. - Wikidata - awgldk - TriplyDB

Oral eplerenone for the management of chronic central serous chorioretinopathy.

Oral eplerenone for the management of chronic central serous chorioretinopathy.

http://www.wikidata.org/entity/Q35549958

about

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.Finasteride is effective for the treatment of central serous chorioretinopathy.Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.Atypical Central Serous Chorioretinopathy.Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.Eplerenone Versus Observation in the Treatment of Acute Central Serous Chorioretinopathy: A Retrospective Controlled Study.Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature

P2860

Q30490648-83E30E7D-4359-4456-96CA-75EBD234B0ED Q36663776-57484400-775E-49EA-8FDF-BB648847489B Q37000742-6D7B2FA4-8720-4D24-ABF7-D0FD28A6C9A7 Q38825598-8078074E-62C2-4929-9EC0-6467B13FE33B Q41112838-73DAA262-DF91-4CCE-BA88-F2C627A441D3 Q41464451-A803A216-B0DE-4EA8-BC8E-8663FCAF357A Q49435229-7790D07C-BC14-4F04-91F6-027719ED7A42 Q50016401-CA661D07-A803-4790-8E07-863A641D6C53 Q58720984-A8CB7EB9-CDF5-4CDD-A311-3D785CC94C3D

P2860

Oral eplerenone for the management of chronic central serous chorioretinopathy.

http://www.wikidata.org/entity/Q35549958

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@ast

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@en

type

label

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@ast

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@en

prefLabel

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@ast

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@en

P1433

Q35549958-CFCE2A2C-E7D5-4109-99AD-821062ABF350

P1476

Q35549958-CF798C11-7F6D-42D0-92DC-E045CE3E579E

P2093

Q35549958-4ED1D928-9B15-4396-BFF3-B07E1107D460

Q35549958-6A7A5F3D-0FE4-4AFF-9225-8C5A090C531D

Q35549958-76E7AB97-5747-4FB8-A461-8BE524FCB2B5

Q35549958-9E9127E7-9F5F-47D3-9FC1-79DA0E99C535

Q35549958-C85615B5-0467-41A6-A96B-DD13E5BBA35F

P2860

Q35549958-15395877-A571-4344-85AD-C7B832E02C48

Q35549958-73AD851F-8772-4D7F-9CD0-431BF38F6037

Q35549958-74092515-6CB8-4794-9EF4-472EF5E759B2

Q35549958-7929FA93-5856-4266-B0B8-C6D76D0A4E31

Q35549958-93DB03C5-3A1D-4854-8715-D197E5F60728

Q35549958-A0BDA8D8-ABFB-4A37-AB54-5ACC60CB1949

Q35549958-AC001690-8653-452C-8AC5-DA140D875A28

Q35549958-BACD4E89-5462-4484-95B5-9FAFB3F43FFB

Q35549958-D0E27474-6090-4001-BE2F-CC912D19CB17

P304

Q35549958-829761CC-2375-4DCC-B7BC-DE4A93C79676

P31

Q35549958-BE43967B-E90F-4BDE-A722-B3F87C647A61

P356

Q35549958-FCDD595F-7429-441F-A5F9-DB752E75EDA3

P433

Q35549958-D7571CCD-2BF7-4C3C-84FD-1D28CC7C1840

P478

Q35549958-9CAD6F75-8B9C-4C98-B0CB-FCEC9F7BA15A

P50

Q35549958-E3A877CA-6257-47A8-A78D-EF679EF5949E

P577

Q35549958-9FE884A9-0A57-484E-B65B-2429ECCE4E62

P698

Q35549958-F81DD70B-ABE5-4B0D-AF74-6D68A0A440F2

P932

Q35549958-B6E3730C-9543-4422-86B6-96DCED592AB3

P356

J.ISSN.2222-3959.2015.02.17

P1433

International Journal of Ophthalmology

P1476

Oral eplerenone for the management of chronic central serous chorioretinopathy.

@en

P2093

Andrew P Schachat

http://www.w3.org/2001/XMLSchema#string

Jonathan E Sears

http://www.w3.org/2001/XMLSchema#string

Justis P Ehlers

http://www.w3.org/2001/XMLSchema#string

Rishi P Singh

http://www.w3.org/2001/XMLSchema#string

Rumneek Bedi

http://www.w3.org/2001/XMLSchema#string

P2860

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

Central serous chorioretinopathy: an update on pathogenesis and treatment.

Diagnosis and interventions for central serous chorioretinopathy: review and update.

Central serous chorioretinopathy and glucocorticoids.

Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy

Central serous chorioretinopathy and indocyanine green angiography.

Digital indocyanine green videoangiography of central serous chorioretinopathy.

Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.

Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report.

P304

310-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3980/J.ISSN.2222-3959.2015.02.17

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25938046

http://www.w3.org/2001/XMLSchema#string

P932

4413566

http://www.w3.org/2001/XMLSchema#string